Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281931
Status:
TERMINATED
Last Update Posted:
2016-09-26
First Post:
2006-01-24
Brief Title:
Fludarabine Cyclophosphamide and Rituximab in Treating Patients With Prolymphocytic Leukemia
Sponsor:
German CLL Study Group
Organization:
German CLL Study Group
Organization Data
Organization:
German CLL Study Group
Class:
OTHER
Study ID:
PLL1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German CLL Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None